Cargando…
A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC
Colorectal cancer (CRC) is a highly heterogeneous disease, for which prognosis has been relegated to clinicopathologic staging for decades. There is a need to stratify subpopulations of CRC on a molecular basis to better predict outcome and assign therapies. Here we report targeted exome-sequencing...
Autores principales: | Schell, Michael J., Yang, Mingli, Teer, Jamie K., Lo, Fang Yin, Madan, Anup, Coppola, Domenico, Monteiro, Alvaro N. A., Nebozhyn, Michael V., Yue, Binglin, Loboda, Andrey, Bien-Willner, Gabriel A., Greenawalt, Danielle M., Yeatman, Timothy J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912618/ https://www.ncbi.nlm.nih.gov/pubmed/27302369 http://dx.doi.org/10.1038/ncomms11743 |
Ejemplares similares
-
Co-Evolution of Somatic Variation in Primary and Metastatic Colorectal Cancer May Expand Biopsy Indications in the Molecular Era
por: Kim, Richard, et al.
Publicado: (2015) -
An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy
por: Yang, Mingli, et al.
Publicado: (2022) -
APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes
por: Thota, Ramya, et al.
Publicado: (2021) -
Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer
por: Omolo, Bernard, et al.
Publicado: (2016) -
Whole Genome Sequencing Analysis of a Stage IV Colon Cancer Patient with a 10-Year Disease-Free Survival following Systemic Chemotherapy/Bevacizumab
por: Yeatman, Timothy J., et al.
Publicado: (2018)